VOLLMAR Wissen+Kommunikation

In my previous post, I argued that the medical technology sector offers valuable lessons for building reliable AI systems—particularly through Good Machine Learning Practice (GMLP). With the “Guiding Principles of Good AI Practice in Drug Development”, jointly published by theweiterlesen

It is quite rare for my two main areas of consultancy – knowledge management and computerised system validation in the pharmaceutical sector – to overlap, but when it comes to AI… Whilst many companies are still experimenting with prototypes, theweiterlesen